MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Interaction between mGluR5 and NR2B is increased in 6-OHDA parkinsonian rats with L-dopa-induced dyskinesiaInteraction between mGluR5 and NR2B is increased in 6-OHDA parkinsonian rats with L-dopa-induced dyskinesia

    J.Y. Lin, Z.G. Liu, C.L. Xie, A.J. Yan (Shanghai, China)

    Objective: In this study, we verified whether the interaction of mGluR5 and NR2B exerts an important effect on the development of LID. Background: L-dopa is…
  • 2018 International Congress

    A framework to facilitate competence in practice for Parkinson’s Disease Nurse Specialists in the United Kingdom

    H. Martin, J. Price, L. Ebenezer (Coventry, United Kingdom)

    Objective: To determine if the current Parkinson's Disease Nurse Specialist (PDNS) competency framework 2nd Edition 2008 (1) for nurses working in the management of Parkinson's…
  • 2018 International Congress

    Knowledge of Parkinson’s Disease in Urban Population of Kyrgyz Republic

    C. Shambetova, A. Arykova, I. Nisheglotova, B. Abdildaev, SY. Lim, AH. Tan (Bishkek, Kyrgyzstan)

    Objective: To assess public knowledge of Parkinson's disease (PD) in an urban population in Kyrgyz Republic. Background: Poor awareness and knowledge regarding PD among the…
  • 2018 International Congress

    The role of Genes and Gene x Environment Determinants of Stress in the pathogenesis of Functional Neurological Disorders

    P. Spagnolo, C. Maurer, C. Hodgkinson, D. Goldman (Bethesda, MD, USA)

    Objective: The aim of the current study was to evaluate the association between common single nucleotide polymorphisms (SNPs) at the level of genetic loci involved…
  • 2018 International Congress

    The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

    Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…
  • 2018 International Congress

    Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

    J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)

    Objective: To investigate whether alterations of cortical thickness correspond to cognitive dysfunction in XDP patients. Background: X-linked dystonia-parkinsonism (XDP) is a severe, hereditary movement disorder…
  • 2018 International Congress

    Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

    P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)

    Objective: Using multimodal MRI, the aim of the study was to evaluate brain changes due to disease progression in multiple system atrophy (MSA) patients. Background:…
  • 2018 International Congress

    Differential glial and neuronal response in Lipopolysaccharide induced Parkinson’s disease model: Modulation with Apocyanin and Curcumin

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: To understand the differential susceptibility of neuronal and glial populations to lipopolysaccharide (LPS) mediated insult in an animal model of PD. Also, to test…
  • 2018 International Congress

    Evaluating long-term effectiveness of carbidopa/levodopa enteral suspension in advanced Parkinson’s Disease patients: PROviDE study design and baseline characteristics

    R. Pahwa, R. Dorsey, P. Kandukuri, Y. Bao, J. Zamudio, I. Pan, Y. Jalundhwala (Kansas City, KS, USA)

    Objective: To evaluate the real-world long-term effectiveness of CLES on advanced PD patients and their caregivers. Background: Carbidopa/levodopa enteral suspension (CLES) was approved in USA…
  • 2018 International Congress

    Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

    I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)

    Objective: The goal of this project is to examine if there is evidence to suggest that there is a difference in response to levodopa during…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley